Skye Bioscience, Inc. (SKYE) CBeyond Phase 2a Clinical Trial Topline Data Conference Call

Core Insights - Skye Biosciences is conducting a conference call to discuss the Phase IIa top line clinical trial results [1] Group 1 - The conference call is led by Bernie Hertel, Head of Investor Relations [1]